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Abstract
Objectives: E. coli is one of the first gram-negative organism colonizing 
the intestine of infants, and it’s commonly causes various community-
acquired and nosocomial bacterial infection in infants. This study 
explores the relationship between the incidence of antimicrobial 
resistance profile and virulence factors genes of E. coli colonizing the 
intestine of infants.
Methods: A total of 150 fecal E. coli isolates from infants aged less than 
one year, who were admitted to Pediatric Clinics at The Jordan University 
Hospital, Amman, Jordan, were investigated for their antimicrobial 
resistance profile and 11 common virulence factors using PCR. 
Results: A total of 134/150 (89.3%) were multidrug resistant (MDR) 
to at least 3 antibiotic classes. Hospitalized infants carried significantly 
more MDR E. coli than non-hospitalized. The majority of E. coli isolates 
carried the virulence factors; aerobactin (33.3%), type1 fimbriae 
(27.3%), S.fimbriae (20%), followed by P.fimbriae (18%), haemolysin 
(14.7%), papG class II (12.0%), and papG class III (7.3%), whereas all 
isolates were negative for capsular antigens K1 and K5 genes, papG 
adhesion `Class I and Dr haemagglutinin. Hospitalized infants carried 
significantly more MDR isolates than nonhospitalized infants, and the 
type of milk feeding was not significantly associated with MDR isolates 
in both groups. 
Conclusion: This study showed that increased presence of antimicrobial 
resistance markers (≥ 6) in E. coli isolates were significantly (P= 0.001) 
associated with less presence of potential virulence genes. 
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Introduction
Escherichia coli is the most common facultative 
anaerobic bacterium colonize intestines of all hu-
mans. The organism can be frequently detected 
after few days in the new born baby’s feces and 
become part of their intestinal normal microflora. 
Intestinal colonizing of the newborn infant with E. 
coli may originate from the maternal fecal flora, 
close contact with mother or nursing staff and hos-
pital environment [1].
Fecal E. coli strains express frequently a broad va-
riety of virulence factors involved in the colonization, 
adhesion, invasion, and survival of host defenses 
[2]. E. coli strains causing extra-intestinal infections 
especially cystitis, pyelonephritis or prostatitis carry 
a patterns of virulence genes, including commonly 
P fimbriae, capsules, haemolysin and siderophore 
aerobactin [ 3]. 
Most people have one or few biotypes of E. coli 
strains in their intestine at any time in their life, 
some of these strains colonize the intestine for 
months and years, while others found as transient 
strains with low colonizing capacities and disappear 
within some weeks [ 4]. 
Recent studies from various countries have re-
ported increased intestinal colonization and infec-
tion of infants with extended-spectrum β-lactamase 
(ESBL)-producing E. coli [5-6]. ESBL-producing E. coli 
has been widely associated with both hospitalized 
and community-acquired infections worldwide [7-
10]. 
The relationship between incidence of virulence 
factors and antibiotic resistance in E. coli is still not 
well studied. A study of Cooke et al. 11 found that 
the majority of virulence factors were equally distrib-
uted between antibiotic-susceptible and multiple-
drug-resistant (MDR) E. coli isolates, while a study 
of Karami et al., [12] has suggested that the pres-
ence of antibiotic resistance in E. coli strains might 
be associated with increased presence of certain 
virulence genes than susceptible E. coli strains. 
The objective of this study was to investigate oc-
currence of antimicrobial resistance and potential 
virulence factor genes in fecal E. coli isolates of in-
fants.
Patients and Materials 
Patients. A total of 150 infants aged between 
1-day to 1-year were included in this study after 
their admission for medical investigation at the pe-
diatric department/The Jordan University Hospital in 
Amman. Of these, 98 (65.3%) were males and 52 
(34.7%) were females. The age of children were cat-
egorized into 4 age groups (Table 1). The study has 
been approved by the high graduate committees 
of the Faculty of Medicine, the ethics committee of 
Jordan Hospital University, and Faculty of Graduate 
Studies/University of Jordan, Amman-Jordan and in-
formed consent was obtained from mother of each 
infant. 
Collection of fecal specimens. All collected 
fecal swabs from infants were cultured within one 
hour on MacConkey agar and incubated for 24 
hr in 37°C,and all fecal samples grew E. coli. Five 
colonies that morphologically represent E. coli- like 
Table 1 .  Distribution of 134 MDR E. coli isolates 
according to the age of non-hospitalized 
and hospitalized infants*
Infant  age 
group
No. (%)  
Non-hospitalized 
infants
No. (%)
Hospitalized  
infants*
No % No %
1-30 days 4 16 56 51.3
1-3 months 13 52 15 13.8
3-6 months  8 32 16 14.7%
6-12 months  0 0 22 20.2
Total 25/134 16.7% 109/134 81.3%**
* All were treated with antibiotics during their stay at the hospital
**P= < 0.05.
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growth were selected and sub-cultured on MacCo-
nkey again to obtain pure E. coli isolates. All E. coli 
isolates were confirmed using commercial Remel 
RapID ONE test (Remel INC, USA). 
 Antimicrobial Susceptibility Testing. This 
procedure was performed according to the recom-
mendation of the Clinical Laboratory and Standards 
Institute (CLSI,2012) [13]. The results were interpret-
ed also according to the guidelines of CLSI. The 
antimicrobials used in our study (µg/disk) were pre-
sented in Table 2. 
E. coli DNA extraction. The bacterial DNA was 
extracted using the G-spin™ Total DNA Extraction 
Kit (iNtRon, Gyeonggi-do, Korea) according to the 
manufacturer’s protocol for isolation of bacterial 
DNA from biological fluids. All DNA preparations 
were tested by spectrophotometer to ensure a suf-
ficient quantity of DNA for PCR amplification.
Multiplex PCR tests for detection potential 
virulence factor genes
All virulence factor genes of E. coli isolates were 
detected using three sets of multiplex PCRs as de-
scribed by Nowrouzian et al., [14]. The first PCR set 
included primer pairs for detection Type1 fimbriae,S 
fimbriae, P fimbriae as well as Dr haemagglutinin. 
The second PCR set composed of primer pairs for 
detection the three papG alleles, and the third PCR 
set included primer pairs for detection haemolysin, 
aerobactin and the capsular antigens K1 and K5.
 Concentrations and cycling conditions. The 
amplification was performed in a total volume of 
50 µL using Fast Ready Master Mix (Promega, USA). 
The primer concentration used was 1 µM of each 
primer and a volume of 3 µL of the extracted DNA. 
The following PCR conditions were set for all 
tests as follow; initial denaturation at 94 ºC for 4 
minutes, followed by 25 cycles of denaturation at 
94ºC for 2 minutes, annealing at 65 ºC for 1minute, 
and extension at 72 ºC for 2 minute, and a final 
extension at 72 ºC for 3 minutes. 
 Gel electrophoresis. PCR products using 5 µL 
of each amplified sample were analyzed in agarose 
gel (2%) including ethidium bromide. A control 100 
bp DNA ladder was add for each run. The agrose 
gels were run for 45 minutes at 160 volts using hori-
zontal electrophoresis apparatus, and the gels were 
visualized under ultraviolet light using gel documen-
tation system (UVP, USA). A strain of E. coli ATCC 
51446 was included as a positive control in PCR for 
detection of virulence factor genes, and nuclease 
free water was used as a negative control. 
Table 2. Antimicrobial susceptibility pattern of 150 E. coli isolates*
Antibiotic
 
No. (%) Resistant
E. coli isolates 
 No. (%) 
R-markers
Pattern of antimicrobial resistance phenotypes 
(No. R-markers) 
Augmentin (AUG) 141  94 30(22) AUG,NA,TS (3) 
Cefuroxime (CXM) 78 52 26 (19.4) AUG,TS, NA, NI (4)
Cotrimoxazole (TS)  78  52 20(14.9) AUG,TS,NI,GM,CXM (5) 
Nitrofuronatoin(NI) 78  52 19(14.2) AUG,TS,CXM,NA,NI,CTX (6)
Nalidixic acid (NA)  77  51 19(14.2) AUG,TS,CXM,NA,NI,CTX,GM(7)
Cefotaxime (CTX)  76  50 11(8.2) AUG,TS,CXM,NA,NI,CTX,GM,CIP(8)
Gentamicin (GM) 71  47 9(6.7) AUG,TS,CXM,NA,NI,CTX,GM,FOX,IM (9)
Ciprofloxacin(CIP)  29  19 
Imipenem (IM)  14  9.3 
*A total of 58 E. coli isolates were resistant to 6 and more antimicrobial agents. 
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Statistical Analysis
Data were analyzed using Statistical Package for 
Social Sciences (IBM -SPSS) version 20. Frequency 
and percentage were calculated for each virulence 
factor associated with antimicrobial resistance fac-
tors. The level of significance was set at a p value 
of 0.05 to test the hypothesis of no association. 
Fisher’s exact test replaces chi-squared test when 
the minimum expected count is less than five.
Results
A total of 134/150 (89.3%) MDR E. coli isolates 
to 3 ≥drug classes from infant fecal samples were 
recorded (Table 1). The majority of hospitalized in-
fants (81.3%) harbored significantly more MDR E. 
coli isolates (P= < 0.05) than non-hospitalized over 
the same study period. There was no significant dif-
ference between total incidence of MDR E. coli iso-
lates among infants in association with their types 
of milk feeding (breast feeding, formula or mixed) 
(Table 1). The distribution of 134 MDR E. coli iso-
lates with different resistance patterns is shown in 
Table 2. The distribution of virulence genes among 
150 E. coli isolates is shown in Table 3. The major-
ity of E. coli isolates carried different rates of viru-
lence genes; including aerobactin (33.3%), type 1 
fimbriae (27.3%), S fimbriae (20%) Followed by P 
fimbriae(18%), haemolysin (14.7%), pap G class II 
(12.0%), and papG class III (7.3%). The results in-
dicate that virulence genes were mostly detected 
in E. coli isolates (92/150; 61.4%) with few num-
ber of antibiotic resistance markers (1-5). Increased 
number of antimicrobial resistance markers (≥ 6) 
among E. coli isolates (58/150; 38.6%) was associ-
ated significantly(P =0.001) with less presence of 
potential virulence factor genes. 
Discussion
This study has shown that multidrug resistance 
(MDR) E. coli can rapidly colonizing the intestine of 
the majority of Jordanian new borne infants (89.3%) 
within one year-old as demonstrated in their fecal 
samples, particularly during hospitalization.This re-
sult showed higher incidence of MDR E. coli isolates 
than previous studies carried out in Jordan on fecal 
E. coli isolates from infants and adults over the last 
8-year [5,15-16], however, it is important to note 
her that this study included more hospitalized pa-
tients than other studies. A recent study has also 
demonstrated high occurrence rate of CTX-M ESBL-
producing E. coli colonizing the intestine of Jorda-
nian infants at the same Jordan University Hospital [ 
5]. It has been documented that CTX-M-15 group is 
widely prevalent among Enterobacteriaceae in Arab 
Middle East region and mostly associated with MDR 
organisms [10].
Numerous studies have demonstrated that E. coli 
colonizing human intestines might spread to other 
body sites and causes extra-intestinal infections, es-
Table 3.  Distribution of virulence genes among 
150 E. coli isolates* 
Virulence
Factors
Virulence 
Genes
No. (%)
P fimbriae papC 27(18) 
S fimbriae sfaD/E 30 (20)
Type 1 fimbriae fimA 41 (27.5)
papG adhesion `Class I ` papG 0
papG adhesion `Class II papG 18 (12)
papG adhesion `Class III papG 11 (7.3)
Dr haemagglutinin draA 0 
Capsule K1 neuB 0 
Capsule K5 kfiC 0 
Aerobactin iutA 50 (33.3)
Haemolysin HlyA 22 (14.7)
* MDR E. coli isolates (58) carried 6-9 antimicrobial R-markers 
were associated with significantly (P= 0.001) less virulence factors. 
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pecially blood sepsis and meningitis in infants and 
urinary tract infections in all ages [17-19] Therefore, it 
is expected that presence of MDR among fecal E. coli 
strains in infants would be certainly complicated suc-
cessful antimicrobial treatment, particularly if these 
are associated with ESBL- producing   E. coli  strains 
which are currently emerging worldwide [10,20].
E. coli expresses a variety of virulence genes which 
are involved in adhesion, colonization and invasion, 
and those E. coli strains which carry few virulence 
factor genes rarely cause extraintestinal infections, 
especially urinary tract infections [ 2,17]. The pres-
ent study showed that 61% of E. coli fecal isolates 
carried at least 5 virulence genes (Table 3). This 
study has also demonstrated that potential virulence 
genes were distributed in various rates among all E. 
coli isolates in association with presence of 1-5 anti-
microbial resistance markers, while all isolates with 
antimicrobial resistance markers of ≥6 were sig-
nificantly (P= 0.001) carried less potential virulence 
genes. Few previous studies have also reported that 
presence of quiniolone / fluoroquinolone resistance 
in E. coli is associated with less virulence factors and 
less capability of these strain to cause urinary tract 
infection [ 21-24]. However, the study of Cooke et 
al. [11], investigated frequencies of virulence factors 
and multidrug resistance between community and 
nosocomial E. coli isolates from bloodstream and 
found that the majority of virulence factors were 
equally distributed between antibiotic-susceptible 
and multiple-drug-resistant isolates. In addition, the 
overall virulence factor score was higher for isolates 
from community and health care-associated origin 
than those of nosocomial origin. Therefore, the link 
between antimicrobial resistance and virulence fac-
tors in clinical E. coli isolates remains unclear, and 
depends on the interactions between the phyloge-
netic background of the strain and the type of re-
sistance determinant and source of the E. coli strains 
either from clinical infection or colonization site [21].
 In conclusion, this study provides new insights 
into the relationships between increased presence 
of antimicrobial resistance markers (≥6) in fecal E. 
coli isolates from infants and the less presence of 
important potential virulence factors which are nec-
essary to enhance their potential extra-intestinal in-
fections.
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